glp-1 cardiovascular outcomes trial results august 2025 Agonists in Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies SGLT2 Inhibitors and GLP-1 Receptor

Tirzepatide works by targeting two key receptors: the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors

Current uses of dietary therapy for patients with far-advanced CKD

Perimenopause timeline and hormone changes What perimenopause is: Transition phase before menopause Typically begins ages 40-50 (average 45) Lasts 4-8 years on average (varies widely) Ends 12 months after final period Hormones fluctuate wildly (not just decline) Hormone patterns during perimenopause: Estrogen: Up and down unpredictably (not just low) Progesterone: Declines earlier than estrogen Testosterone: Gradual decline begins Growth hormone: Significant drop (20-30% by age 40) Thyroid: Often becomes imbalanced Cortisol: Increases (stress response changes) Why this is harder than menopause: Menopause = low hormones (predictable) Perimenopause = chaotic fluctuations (unpredictable) Can't predict how you'll feel day to day Harder to treat with traditional HRT Learn about peptides , how peptides work , and what are peptides used for in our foundational guides

[DOI] [PMC free article] [PubMed] [Google Scholar] 31.Kalas M.A., Dang T.Q., Galura G., Alvarado L., Dwivedi A.K., Deoker A., McCallum R